[go: up one dir, main page]

MX2017009714A - Metodos para producir compuesto de pirazin carboxamida e intermediario sintetico del mismo. - Google Patents

Metodos para producir compuesto de pirazin carboxamida e intermediario sintetico del mismo.

Info

Publication number
MX2017009714A
MX2017009714A MX2017009714A MX2017009714A MX2017009714A MX 2017009714 A MX2017009714 A MX 2017009714A MX 2017009714 A MX2017009714 A MX 2017009714A MX 2017009714 A MX2017009714 A MX 2017009714A MX 2017009714 A MX2017009714 A MX 2017009714A
Authority
MX
Mexico
Prior art keywords
carboxamide compound
synthetic intermediate
pyrazine carboxamide
production
producing
Prior art date
Application number
MX2017009714A
Other languages
English (en)
Inventor
Morinaga Yasuhiro
Shimada Itsuro
Akiba Takahiro
Hoshii Hiroaki
Komenoi Kousuke
Nishikawa Kentaro
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of MX2017009714A publication Critical patent/MX2017009714A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • A61K31/497Non-condensed pyrazines containing further heterocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

[Problema] Se proporciona un método novedoso para producir un compuesto de pirazin carboxamida como un material de producción de preparación de farmacéuticos, etc.; y un intermediario sintético que es útil en dicho método de producción. [Solución] Como un resultado de la investigación cuidadosa en los métodos de producción para producir industrialmente un compuesto de pirazincarboxamida, los inventores ha encontrado que, al usar un material e intermediario sintético predeterminados, el compuesto de pirazin carboxamida puede ser producido de acuerdo a un método que es apropiado para producción industrial como un producto farmacéutico, sin requerir la purificación por cromatografía de columna en gel de sílice, y en el cual el rendimiento total es mejorado considerablemente, por ello completando la invención actual.
MX2017009714A 2015-01-28 2016-01-27 Metodos para producir compuesto de pirazin carboxamida e intermediario sintetico del mismo. MX2017009714A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015014533 2015-01-28
PCT/JP2016/052229 WO2016121777A1 (ja) 2015-01-28 2016-01-27 ピラジンカルボキサミド化合物の製造方法及びその合成中間体

Publications (1)

Publication Number Publication Date
MX2017009714A true MX2017009714A (es) 2017-11-17

Family

ID=56543388

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017009714A MX2017009714A (es) 2015-01-28 2016-01-27 Metodos para producir compuesto de pirazin carboxamida e intermediario sintetico del mismo.

Country Status (6)

Country Link
JP (1) JPWO2016121777A1 (es)
KR (1) KR20170105021A (es)
CN (1) CN107207468A (es)
CA (1) CA2975072A1 (es)
MX (1) MX2017009714A (es)
WO (1) WO2016121777A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190282569A1 (en) * 2016-10-26 2019-09-19 Astellas Pharma Inc. Stable pharmaceutical composition
EP4159731A4 (en) * 2020-06-01 2024-06-26 Wigen Biomedicine Technology (Shanghai) Co., Ltd. New pyrazine compound
AU2022426699A1 (en) 2021-12-30 2024-07-11 Biomea Fusion, Inc. Pyrazine compounds as inhibitors of flt3
IL317645A (en) * 2022-06-14 2025-02-01 Principia Biopharma Inc Methods for preparing tolbrutinib

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5754177A (ja) * 1980-09-19 1982-03-31 Teikoku Hormone Mfg Co Ltd Chikanchiazoorujudotai
JP3534903B2 (ja) * 1995-06-09 2004-06-07 鐘淵化学工業株式会社 1−[3−クロロ−(2s)−メチルプロピオニル]−ピロリジン−(2s)−カルボン酸の製造方法
ME02648B (me) * 2012-01-17 2017-06-20 Astellas Pharma Inc Jedinjenje pirazin karboksamida

Also Published As

Publication number Publication date
JPWO2016121777A1 (ja) 2017-11-02
CA2975072A1 (en) 2016-08-04
WO2016121777A1 (ja) 2016-08-04
CN107207468A (zh) 2017-09-26
KR20170105021A (ko) 2017-09-18

Similar Documents

Publication Publication Date Title
MX2017009714A (es) Metodos para producir compuesto de pirazin carboxamida e intermediario sintetico del mismo.
MY160954A (en) Agomelatine intermediates and preparation method thereof
MX2016012851A (es) Un metodo para producir 1,1,2,3-tetracloropropeno con alto rendimiento.
WO2015188243A9 (en) PROCESS FOR PREPARING IMATINIB AND IMATINIB MESYLATE NON-NEEDLE SHAPED α2 FORM
FR2986000B1 (fr) Procede de production d'acrylate de 2-octyle par transesterification
CN106146363A (zh) 医药原料3-甲基亚磺酸胺盐的合成方法
CN106117210A (zh) 医药中间体羟基3-羟基吡咯嘧啶的合成方法
CN105753771A (zh) 医药中间体反式3-叔丁氧羰基氨基哌啶的合成方法
CN106117209A (zh) 医药中间体反式叔丁氧羰基-4-吡咯嘧啶的合成方法
CN106117105A (zh) 医药中间体反式叔丁氧羰基-3-羟乙基吡咯烷酮的合成方法
CN106117107A (zh) 医药中间体1-叔丁氧羰基-4-甲基吡咯烷酮的合成方法
CN106117106A (zh) 医药中间体1-叔丁氧羰基-3-乙基吡咯烷酮的合成方法
CN106117102A (zh) 医药中间体反式3-叔丁氧羰基氨基吡咯烷的合成方法
CN106146376A (zh) 医药中间体反式叔丁氧羰基-2-甲基吡咯烷酮的合成方法
CN106117149A (zh) 医药中间体1,3-二氯-5-三氟甲基嘧啶的合成方法
CN106117103A (zh) 医药中间体1-叔丁氧羰基-3-(甲氧基-甲基-氨基甲酰)吡咯烷的合成方法
CN106117136A (zh) 医药原料1,3-二氟吡啶的合成方法
CN106117124A (zh) 医药原料3-溴-5-氟吡啶的合成方法
CN106117208A (zh) 医药中间体5-羟乙基吡咯嘧啶的合成方法
CN106117127A (zh) 医药原料1,4-二溴吡啶的合成方法
CN106146499A (zh) 医药中间体5-三氟乙基鸟嘌呤的合成方法
CN106117126A (zh) 医药原料2-溴-4-氟吡啶的合成方法
CN106496134A (zh) 医用原料5‑氟‑2‑甲基‑4‑嘧啶胺的合成方法
CN106117108A (zh) 医药中间体1-叔丁氧羰基-3-甲基吡咯哌啶的合成方法
CN105753773A (zh) 医药原料2-氯-4-氟吡啶的合成方法